Trials / Unknown
UnknownNCT04107571
A Registry Study on Serumal Biomarkers About Adverse Events in Patients Undergoing Coronary Artery Bypass Grafting.
A Chinese Registry to Determine the Serumal Biomarkers for Prognosis of Adverse Events in Patients Undergoing Coronary Artery Bypass Grafting.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Beijing Institute of Heart, Lung and Blood Vessel Diseases · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a national registry study to determine the serumal biomarkers for prognosis of adverse events in patients undergoing coronary artery bypass grafting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | A type of operation for coranary heart disease patients. | A type of operation for coranary heart disease patients. |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2024-01-01
- Completion
- 2024-06-01
- First posted
- 2019-09-27
- Last updated
- 2019-09-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04107571. Inclusion in this directory is not an endorsement.